163 related articles for article (PubMed ID: 12644546)
1. Re: Serum proteomic patterns for detection of prostate cancer.
Diamandis EP
J Natl Cancer Inst; 2003 Mar; 95(6):489-90; author reply 490-1. PubMed ID: 12644546
[No Abstract] [Full Text] [Related]
2. [PSA-screening: sensible or meaningless?].
Dubben HH
Urologe A; 2009 Sep; 48(9):1103; author reply 1103-4. PubMed ID: 19727645
[No Abstract] [Full Text] [Related]
3. [Early detection of prostate cancer: is serum PSA testing alone sufficient?].
Börgermann C; Vom Dorp F; Breuer G; Kliner S; Rübben H
Urologe A; 2010 Nov; 49(11):1351-5. PubMed ID: 20959954
[TBL] [Abstract][Full Text] [Related]
4. [Prostate-specific antigen for treatment monitoring].
Graefen M; Fröhner M; Wirth M
Urologe A; 2011 Mar; 50(3):309-12. PubMed ID: 21365346
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment.
Ploussard G
J Urol; 2014 Mar; 191(3):637. PubMed ID: 24291165
[No Abstract] [Full Text] [Related]
6. A novel ensemble strategy for classification of prostate cancer protein mass spectra.
Assareh A; Moradi MH; Esmaeili V
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5988-91. PubMed ID: 18003378
[TBL] [Abstract][Full Text] [Related]
7. Serum proteomic patterns for detection of prostate cancer.
Petricoin EF; Ornstein DK; Paweletz CP; Ardekani A; Hackett PS; Hitt BA; Velassco A; Trucco C; Wiegand L; Wood K; Simone CB; Levine PJ; Linehan WM; Emmert-Buck MR; Steinberg SM; Kohn EC; Liotta LA
J Natl Cancer Inst; 2002 Oct; 94(20):1576-8. PubMed ID: 12381711
[TBL] [Abstract][Full Text] [Related]
8. Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
Loeb S; Metter EJ; Carter HB
J Natl Cancer Inst; 2011 Nov; 103(21):1636-7; author reply 1637. PubMed ID: 21926375
[No Abstract] [Full Text] [Related]
9. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
[No Abstract] [Full Text] [Related]
10. [Do current studies really prove the uselessness of PSA screening? : Attempt at a critical interpretation of the publicized data and the resulting echoes in the media].
Stöckle M
Urologe A; 2009 Aug; 48(8):912-6. PubMed ID: 19618157
[No Abstract] [Full Text] [Related]
11. Words of wisdom. Re: PSA density improves prediction of prostate cancer.
Roobol MJ
Eur Urol; 2014 Nov; 66(5):964-5. PubMed ID: 25763443
[No Abstract] [Full Text] [Related]
12. Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?
Carroll PR
Urology; 2001 Apr; 57(4):591-3. PubMed ID: 11306354
[No Abstract] [Full Text] [Related]
13. [Clinical usefulness of the free and total prostate specific antigen ratio in the diagnosis of cancer of the prostate].
Morote J; Encabo G; Andreu J; de Torres I
Med Clin (Barc); 1996 Dec; 107(20):795-6. PubMed ID: 9019610
[No Abstract] [Full Text] [Related]
14. [Role of the markers PAP-PSA in the diagnosis of cancer of the prostate].
Petrone U; Gaspari G; Marascia G; Magnocavallo N; Petrone D; Tucci C
Minerva Urol Nefrol; 1990; 42(2):73-5. PubMed ID: 1697431
[TBL] [Abstract][Full Text] [Related]
15. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
Siegel C
J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
[No Abstract] [Full Text] [Related]
16. [Related biomarkers in the diagnosis of prostate cancer].
Xu YM; Liu HZ
Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
[TBL] [Abstract][Full Text] [Related]
17. Other assessments: prostate size and prostate specific antigen.
Williams G
BJU Int; 2000 Mar; 85 Suppl 1():31-5. PubMed ID: 10756703
[No Abstract] [Full Text] [Related]
18. Prostatic specific antigen (PSA).
Alberti C
Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
[No Abstract] [Full Text] [Related]
19. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
Grond A
Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
[No Abstract] [Full Text] [Related]
20. Reconsidering Prostate Cancer Screening.
Schmidt C
J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
